In Vitro Lung Model Market to Reach US$ 701.81 Mn at a CAGR of 16.2% in 2027 | The Insight Partners

In Vitro Lung Model Market to 2027- Global Analysis and Forecasts by Type (2D, 3D); Application (Drug Screening, Toxicology, 3D Model Development, Physiologic Research, Stem Cell Research, Regenerative Medicine) and Geography

Publication Month: Nov 2019 | Report Code: TIPRE00006695 | No. of Pages: 148 | Category: Medical Device | Status: Published

The global in vitro lung model market is anticipated to reach US$ 701.81 Mn in 2027 from US$ 185.80 Mn in 2018. The market is anticipated to grow with a CAGR of 16.2% from 2019-2027.

 

The report provides trends prevailing in the global in vitro lung model market and the factors driving the market along with those that act as hindrances. The market for in vitro lung model is expected to grow, owing to factors such as significant growth in research funding, and increasing adoption of 3d model systems for in vitro studies. Moreover, rising research on lung diseases are likely to have a positive impact on the growth of the market in the coming years.

 

Exhibit: Lucrative Regional Markets




Market Insights
Significant Growth in Research Funding

Research and development is crucial part of the company’s business. The biotechnology companies focus on the research and development (R&D) to come up with new molecules for various therapeutic applications with the greatest medical and commercial potential. The companies are invest majorly on the R&Ds with the aim of developing high quality and innovative products to the market. As per the report of Pharmaceutical Research and Manufacturers of America (PhRMA), the Research and Development expenditure of the biopharmaceutical companies has increased from US$ 49.6 billion 2012 to US$ 58.8 billion in 2015. R&D spending by the major companies operating in this market has increased over the years.

 

Around 60 percent of investigational drugs fail in clinical trials due to a lack of efficiency, in spite of promising results in pre-clinical studies using animal research models. Thus, in September 2017, NIH funded $15 million to develop 3-D human tissue models.

 

Furthermore, InSphero AG, an innovative provider of 3D cell-based platforms for drug discovery and efficacy testing, received USD 10 million to further improve its discovery platforms for metabolic diseases and cancer.

Thus, the growing research funding by the companies operating in this market is likely to favor the growth of the in-vitro lung model market.

 

Rising Research on Lung Diseases

The cases of asthma, lung cancer, and COPD has been growing across the globe at a significant rate. Thus there is a growing need to study lung diseases specifically. Since early 2010’s the practices of creating lab-grown organ buds, mostly referred to as ‘organoids’, have become more popular. These organ buds are miniature organ-like structures that are maintained in the lab, and researchers are able to grow these organoids, which resembles human body tissues. Lung diseases such as chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) among others are significantly causing death and illness worldwide. In April 2017, researchers at the University of Michigan Medical School published an “In Vitro Models to Study Human Lung Development, Disease, and Homeostasis” report in PhysIOL journal. The report discussed the current advances in generating in vitro human lung models using cell lines, primary human tissue, and human pluripotent stem cell derived lung tissue. Moreover, Lung cancer cell lines have made a significant contribution to lung cancer research and biomedical discovery. The high similarities between lung cancer cell lines and the lung tumor helps in discovering new drug molecules.

Thus the growing research on lung diseases is expected to offer broad growth opportunities for the in vitro lung model market at the global level.

 

Product Insights

The global in vitro lung model market, based on type, has been segmented into 2D and 3D. The 3D in vitro lung model segment held the largest share of the market in 2018. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

 

Exhibit: In vitro lung model Market, by Type

  

Strategic Insights

Growth strategies through several organic and inorganic such as approvals, product launch, agreements, and partnerships have been witnessed in the market of In vitro lung model. For instance, in June, 2018, The US patent office accepted the patent for the AlveoliX lung-on-chip system which assist is developing drug candidates for lung diseases.

Global In vitro lung model Market – By Type

  • 2D
  • 3D

 

Global In vitro lung model Market – By Application

  • Drug Screening
  • Toxicology
  • 3D Model Development
  • Physiologic Research
  • Stem Cell Research
  • Regenerative Medicine

 

BY GEOGRAPHY

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South and Central America
    • Brazil
    • Argentina

 

Company Profiles

  • Epithelix Sàrl
  • MATTEK
  • LONZA
  • InSphero
  • Emulate, Inc.
  • AlveoliX AG
  • Thermo Fisher Scientific Inc
  • PromoCell GmbH
  • Merck KGaA
  • Horizon Discovery Group plc

 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global In Vitro Lung Model Market – By Type

1.3.2        Global In Vitro Lung Model Market – By Application

1.3.3        Global In Vitro Lung Model Market – By Geography

2.             In Vitro Lung Model Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             In Vitro Lung Model– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        In Vitro Lung Model Market in North America: PEST Analysis

4.2.2        In Vitro Lung Model Market in Europe: PEST Analysis

4.2.3        In Vitro Lung Model Market in APAC: PEST Analysis

4.2.4        In Vitro Lung Model Market in MEA: PEST Analysis

4.2.5        In Vitro Lung Model Market – South and Central America PEST Analysis

4.3       Expert Opinion

5.             Global In Vitro Lung Model Market – Key Industry Dynamics

5.1       Key Market Drivers

5.1.1        Significant Growth in Research Funding

5.1.2        Increasing Adoption Of 3D Model Systems For In Vitro Studies

5.2       Key Market Restraints

5.2.1        Dearth of Skilled Professionals

5.3       Key Market Opportunity

5.3.1        Rising Research on Lung Diseases

5.4       Future Trend

5.4.1        Increasing Number of Start Up Companies

5.5       Impact Analysis

6.             In Vitro Lung Model Market – Global Analysis

6.1       Global In Vitro Lung Model Market Revenue Forecasts And Analysis

6.2       Global In Vitro Lung Model Market, By Geography - Forecasts And Analysis

6.3       Positioning Of Key Players

7.             In Vitro Lung Model Market Analysis And Forecasts To 2027 – Type

7.1       Overview

7.2       Global In Vitro Lung Model Market, By Type 2018 & 2027 (%)

7.3       2D Market

7.3.1        Overview

7.3.2        Global 2D Market Revenue and Forecasts to 2027 (US$ Mn)

7.4       3D Market

7.4.1        Overview

7.4.2        Global 3D Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.3        In House Market

7.4.3.1      Overview

7.4.3.2      Global In House Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.4        Commercial Market

7.4.4.1      Overview

7.4.4.2      Global Commercial Market Revenue and Forecasts to 2027 (US$ Mn)

8.             In Vitro Lung Model Market Analysis And Forecasts To 2027 – Application

8.1       Overview

8.2       Global In Vitro Lung Model Market, By Application 2018 & 2027 (%)

8.3       Drug Screening Market

8.3.1        Overview

8.3.2        Drug Screening Market Revenue and Forecasts to 2027 (US$ Mn)

8.4       Toxicology Market

8.4.1        Overview

8.4.2        Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)

8.5       3D Model Development Market

8.5.1        Overview

8.5.2        Global 3D Model Development Market Revenue and Forecasts to 2027 (US$ Mn)

8.6       Physiological Research Market

8.6.1        Overview

8.6.2        Global Physiological Research Market Revenue and Forecasts to 2027 (US$ Mn)

8.7       Stem Cell Research Market

8.7.1        Overview

8.7.2        Global Stem Cell Research Market Revenue and Forecasts to 2027 (US$ Mn)

8.8       Regenerative Medicine Market

8.8.1        Overview

8.8.2        Global Regenerative Medicine Market Revenue and Forecasts to 2027 (US$ Mn)

9.             In Vitro Lung Model Market Revenue And Forecasts To 2027 – Geographical Analysis

9.1       North America In Vitro Lung Model Market Revenue and Forecasts To 2027

9.1.1        Overview

9.1.2        North America In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.3        North America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.3.1      North America 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.4        North America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.1.5        North America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)

9.1.6        US In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.1      US In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.2      US In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.6.2.1       US 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.6.3      US In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.1.7        Canada In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1      Canada In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.2      Canada In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.2.1       Canada 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.7.3      Canada In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.1.8        Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.1      Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.8.2      Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.8.2.1       Mexico 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.1.8.3      Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.2       Europe In vitro lung model Market Revenue and Forecasts To 2027

9.2.1        Overview

9.2.2        Europe In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.2.1      Europe In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.2.1.1       Europe 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.2.2      Europe In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.2.3        Europe In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)

9.2.4        Germany In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.4.1      Germany In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.4.2      Germany In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.4.2.1       Germany 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.4.3      Germany In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.2.5        UK In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.5.1      UK In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.5.2      UK In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.5.2.1       UK 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.5.3      UK In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.2.6        France In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.1      France In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.2      France In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.6.2.1       France 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.6.3      France In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.2.7        Spain In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.1      Spain In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.2      Spain In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.7.2.1       Spain 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.7.3      Spain In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.2.8        Italy In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.1      Italy In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.2      Italy In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.8.2.1       Italy 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.2.8.3      Italy In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.3       Asia Pacific In Vitro Lung Model Market Revenue and Forecasts To 2027

9.3.1        Overview

9.3.2        Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.3        Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.3.1      Asia Pacific 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.4        Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.3.5        Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)

9.3.6        China In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.6.1      China In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.6.2      China In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.6.2.1       China 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.6.3      China In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.3.7        Japan In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.1      Japan In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.2      Japan In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.7.2.1       Japan 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.7.3      Japan In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.3.8        India In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.8.1      India In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.8.2      India In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.8.2.1       India 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.8.3      India In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.3.9        South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9.1      South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.9.2      South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.9.2.1       South Korea 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.9.3      South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.3.10     Australia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.10.1    Australia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.10.2    Australia In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.10.2.1    Australia 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.3.10.3    Australia In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.4       Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts To 2027

9.4.1        Overview

9.4.2        Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.3        Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.3.1      Middle East & Africa 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.4        Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application  (US$ Mn)

9.4.5        Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)

9.4.6        South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6.1      South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.6.2      South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.6.2.1       South Africa 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.6.3      South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.4.7        Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.7.1      Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.7.2      Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.7.2.1       Saudi Arabia 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.7.3      Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.4.8        UAE In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8.1      UAE In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.8.2      UAE In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.8.2.1       UAE 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.4.8.3      UAE In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.5       South and Central America In Vitro Lung Model Market Revenue and Forecast To 2027

9.5.1        Overview

9.5.2        South and Central America In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)

9.5.3        South and Central America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type  (US$ Mn)

9.5.3.1      South and Central America 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.5.4        South and Central America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.5.5        South and Central America In Vitro Lung Model Market Revenue and Forecast to 2027, By Country (%)

9.5.6        Argentina In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.6.1      Argentina In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)

9.5.6.2      Argentina In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.5.6.2.1       Argentina 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.5.6.3      Argentina In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.5.7        Brazil In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.7.1      Brazil In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)

9.5.7.2      Brazil In Vitro Lung Model Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.5.7.2.1       Brazil 3D Market Revenue and Forecasts to 2027, By Type (US$ Mn)

9.5.7.3      Brazil In Vitro Lung Model Market Revenue and Forecasts to 2027, By Application (US$ Mn)

10.          In Vitro Lung Model Market– Industry Landscape

10.1    Overview

10.2    Growth Strategies in the In Vitro Lung Model Market, 2016-2019

10.3    Organic Growth Strategies

10.3.1     Overview

10.3.1.1    Recent Organic Developments By Players In The In vitro lung model Market

10.4    Inorganic Growth Strategies

10.4.1     Overview

10.4.1.1    Recent Inorganic Developments By Players In The In Vitro lung model Market

11.          In Vitro Lung Model Market–Key Company Profiles

11.1    Epithelix Sàrl

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Financial Overview

11.1.4     Product Portfolio

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2    MATTEK

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Financial Overview

11.2.4     Product Portfolio

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3    LONZA

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Financial Overview

11.3.4     Product Portfolio

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4    InSphero

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Financial Information

11.4.4     Product Portfolio

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5    Emulate, Inc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Financial Overview

11.5.4     Product Portfolio

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6    AlveoliX AG

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Financial Information

11.6.4     Product Portfolio

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7    PromoCell GmbH

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Financial Overview

11.7.4     Product Portfolio

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8    Thermo Fisher Scientific Inc.

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Financial Overview

11.8.4     Product Portfolio

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9    Merck KgaA

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Financial Overview

11.9.4     Product Portfolio

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10 Horizon Discovery Group plc

11.10.1   Key Facts

11.10.2   Business Description

11.10.3   Financial Overview

11.10.4   Product/ Services Portfolio

11.10.5   SWOT Analysis

11.10.6   Key Developments

12.          Appendix

12.1    About The Insight Partners

12.2    Glossary of Terms

 

LIST OF TABLES

Table 1.             R&D Investments by major Biotechnology companies

Table 2.             North America In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 3.             North America 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 4.             North America In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 5.             US In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 6.             US 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 7.             US In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 8.             Canada In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 9.             Canada 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 10.          Canada In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 11.          Mexico In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 12.          Mexico 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 13.          Mexico In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 14.          Europe In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 15.          Europe 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 16.          Europe In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 17.          Germany In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 18.          Germany 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 19.          Germany In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 20.          UK In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 21.          UK 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 22.          UK In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 23.          France In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 24.          France 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 25.          France In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 26.          Spain In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 27.          Spain 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 28.          Spain In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 29.          Italy In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 30.          Italy 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 31.          Italy In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 32.          Asia Pacific In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 33.          Asia Pacific 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 34.          Asia Pacific In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 35.          China In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 36.          China 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 37.          China In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 38.          Japan In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 39.          Japan 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 40.          Japan In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 41.          India In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 42.          India 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 43.          India In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 44.          South Korea In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 45.          South Korea 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 46.          South Korea In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 47.          Australia In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 48.          Australia 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 49.          Australia In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 50.          Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 51.          Middle East & Africa 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 52.          Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 53.          South Africa In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 54.          South Africa 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 55.          South Africa In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 56.          Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 57.          Saudi Arabia 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 58.          Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 59.          UAE In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 60.          UAE 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 61.          UAE In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 62.          South and Central America In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 63.          South and Central America 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 64.          South and Central America In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application  (US$ Mn)

Table 65.          Argentina In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 66.          Argentina 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 67.          Argentina In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 68.          Brazil In Vitro Lung Model Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 69.          Brazil 3D Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 70.          Brazil In Vitro Lung Model Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 71.          Recent Organic Developments in the In vitro lung model Market

Table 72.          Recent Inorganic Developments By Players In The In Vitro lung model Market

Table 73.          Glossary of Terms, in vitro lung model Market


LIST OF FIGURES

Figure 1.           In vitro lung model Market Segmentation

Figure 2.           In vitro lung model Segmentation, By Region

Figure 3.           Global In Vitro Lung Model Market Overview

Figure 4.           3D Segment Held Largest Share Of Type Segment In In Vitro Lung Model Market

Figure 5.           North America Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Global In Vitro Lung Model Market, By Geography (US$ Mn)

Figure 7.           Global In Vitro Lung Model Market- Leading Country Markets (US$ Mn)

Figure 8.           Global In Vitro Lung Model Market, Industry Landscape

Figure 9.           In Vitro Lung Model Market in North America: PEST Analysis

Figure 10.        In Vitro Lung Model Market in Europe: PEST Analysis

Figure 11.        In Vitro Lung Model Market in APAC: PEST Analysis

Figure 12.        In Vitro Lung Model Market MEA: PEST Analysis

Figure 13.        In Vitro Lung Model Market – South And Central America PEST Analysis

Figure 14.        Global In Vitro Lung Model Market Impact Analysis Of Driver and Restraints

Figure 15.        Global In Vitro Lung Model Market – Revenue Forecasts And Analysis – 2018- 2027

Figure 16.        Global In Vitro Lung Model Market – By Geography Forecasts And Analysis – 2018- 2027

Figure 17.        Market Positioning Of Key Player In Global In Vitro Lung Model Market

Figure 18.        Global In Vitro Lung Model Market, by Type 2018 & 2027 (%)

Figure 19.        Global 2D Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Global 3D Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Global in house Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Global Commercial Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        Global In Vitro Lung Model Market, by Application 2018 & 2027 (%)

Figure 24.        Global Drug Screening Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Global Toxicology Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        Global 3D Model Development Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.        Global Physiological Research Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.        Global Stem Cell Research Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.        Global Regenerative Medicine Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.        North America In Vitro Lung Model Market Revenue Overview, By Country (2018) (US$ Mn)

Figure 31.        North America In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 32.        North America In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)

Figure 33.        US In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 34.        Canada In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 35.        Mexico In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 36.        Europe In vitro lung model Market Revenue Overview, By Country (2018) (US$ Mn)

Figure 37.        Europe In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 38.        Europe In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)

Figure 39.        Germany In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 40.        UK In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 41.        France In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 42.        Spain In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 43.        Italy In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 44.        Asia Pacific In Vitro Lung Model Market Revenue Overview, By Country (2018) (US$ Mn)

Figure 45.        Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 46.        Asia Pacific In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)

Figure 47.        China In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 48.        Japan In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 49.        India In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 50.        South Korea In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 51.        Australia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 52.        Middle East & Africa In Vitro Lung Model Market Revenue Overview, By Country (2018) (US$ Mn)

Figure 53.        Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 54.        Middle East & Africa In Vitro Lung Model Market Revenue and Forecasts to 2027, By Country (%)

Figure 55.        South Africa In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 56.        Saudi Arabia In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 57.        UAE In Vitro Lung Model Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 58.        South and Central America In Vitro Lung Model Market Revenue Overview, By Country, 2018 (US$ Mn)

Figure 59.        South and Central America In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)

Figure 60.        South and Central America In Vitro Lung Model Market Revenue and Forecast to 2027, By Country (%)

Figure 61.        Argentina In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)

Figure 62.        Brazil In Vitro Lung Model Market Revenue and Forecast to 2027 (US$ Mn)

Figure 63.        Growth Strategies in the In Vitro Lung Model Market, 2016-2019

The List of Companies

  1. Epithelix Sàrl
  2. MATTEK
  3. LONZA
  4. InSphero
  5. Emulate, Inc.
  6. AlveoliX AG
  7. Thermo Fisher Scientific Inc
  8. PromoCell GmbH
  9. Merck KGaA
  10. Horizon Discovery Group plc

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the in vitro lung model market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global in vitro lung model market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.